VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post by User

VALEANT PHARMACEUTICALS INTL INC

<< Previous

Bullboard Posts

Next >>

Post by coalbeton Apr 15, 2016 5:09pm

169 Views

Post# 24773366

Call options

VRX is up 2.7% ahead of the bell, after closing at $32.37 Thursday, on news that the company is working with investment banks -- including Goldman Sachs Group Inc (NYSE:GS) -- to review options, which could include a sale of some of its businesses. Valeant Pharmaceuticals Intl Inc has been struggling since mid-2015, amid a series of missteps, and most recently received a notice of default from a larger bondholder. But in the options pits, traders on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) have been buying calls at a faster-than-usual clip. The stock's 10-day call/put volume ratio of 2.55 sits higher than 84% of all readings in the past year.